Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer

Published:2016-12 Issue:6 Volume:70 Page:985-992
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Lorente David,Olmos David,Mateo Joaquin,Bianchini Diletta,Seed George,Fleisher Martin,Danila Daniel C.,Flohr Penny,Crespo Mateus,Figueiredo Ines,Miranda Susana,Baeten Kurt,Molina Arturo,Kheoh Thian,McCormack Robert,Terstappen Leon W.M.M.,Scher Howard I.,de Bono Johann S.

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide. IARC CancerBase No. 11;Ferlay,2013

2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

3. Abiraterone in metastatic prostate cancer without previous chemotherapy;Ryan;N Engl J Med,2013

4. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

5. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;N Engl J Med,2014

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancer;Cancer Treatment Reviews;2024-07

2. Deciphering the role of zinc homeostasis in the tumor microenvironment and prognosis of prostate cancer;Discover Oncology;2024-06-04

3. Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA;Clinical Cancer Research;2024-06-03

4. The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta‐analysis;Journal of Evidence-Based Medicine;2024-04-10

5. Minimally invasive cytoreductive radical prostatectomy, exploring the safety and feasibility of a single-port or multi-port robotic platform;BMC Urology;2024-03-26